Atopic Dermatitis: Epidemiology Forecast to 2027

Atopic dermatitis (AD) or atopic eczema is a chronic inflammatory skin disease characterized by itchy skin lesions and rashes. Although the condition affects people of all ages, it is primarily common among infants and children. Modifiable risk factors include inhalant allergens, food allergens, and newborns not being exclusively breastfed, while non-modifiable risk factors include young age and genetics or heritability.

This epidemiology forecast for AD is supported by historical data obtained from peer-reviewed articles and population-based studies. These sources used questionnaires and various diagnostic measures to assess AD symptoms across the 7MM. The forecast methodology was kept consistent across the 7MM to allow for a meaningful comparison of AD across these markets.

In the 7MM, the one-year total prevalent cases of AD are expected to increase from 81,608,107 cases in 2017 to 83,639,767 cases in 2027, at an Annual Growth Rate (AGR) of 0.25%. In the 7MM, the one-year diagnosed prevalent cases of AD are expected to increase from 36,109,879 cases in 2017 to 36,873,084 cases in 2027, at an AGR of 0.21%. In 2027, the US will have the highest number of one-year diagnosed prevalent cases of AD in the 7MM with 18,236,642 diagnosed prevalent cases, whereas Germany will have the fewest number of one-year diagnosed prevalent cases with 1,797,130 cases.

Scope

The Atopic Dermatitis (AD) Epidemiology Forecast Report and Epidemiology Forecast Model provide an overview of the risk factors and global trends of AD in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).

This report also includes a 10-year epidemiological forecast for the one-year total prevalent cases (both diagnosed and undiagnosed) and one-year diagnosed prevalent cases of AD segmented by sex, age, and severity (mild, moderate, and severe) in the 7MM.

The Atopic Dermatitis epidemiology forecast report and model were written and developed by Masters- and PhD-level epidemiologists.

 The Epidemiology Forecast Report is in-depth, high quality, transparent, and market-driven, providing expert analysis of disease trends in the 7MM.

 The Epidemiology Forecast Model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.

Reasons to buy

The Atopic Dermatitis (AD) Epidemiology Forecast series will allow you to:

Develop business strategies by understanding the trends shaping and driving the global AD market.

Quantify patient populations in the global AD market to improve product design, pricing, and launch plans.

Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for AD therapeutics in each of the markets covered.

Understand magnitude of AD population by severity and other clinically relevant segmentations.

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Atopic Dermatitis: Executive Summary

2.1 Related Reports

2.2 ...

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Atopic Dermatitis: Executive Summary

2.1 Related Reports

2.2 Upcoming Related Reports

3 Epidemiology

3.1 Disease Background

3.2 Risk Factors and Comorbidities

3.3 Global and Historical Trends

3.4 Forecast Methodology

3.4.1 Sources

3.4.2 Forecast Assumptions and Methods – Population

3.4.3 Forecast Assumptions and Methods – One-Year Total and Diagnosed Prevalent Cases of Atopic Dermatitis

3.4.4 Forecast Assumptions and Methods – One-Year Total Prevalent Cases of Atopic Dermatitis by Severity

3.4.5 Forecast Assumptions and Methods – One-Year Diagnosed Prevalent Cases of Atopic Dermatitis by Severity

3.5 Epidemiological Forecast for Atopic Dermatitis (20172027)

3.5.1 One-Year Total Prevalent Cases of Atopic Dermatitis

3.5.2 Age-Specific One-Year Total Prevalent Cases of Atopic Dermatitis

3.5.3 Sex-Specific One-Year Total Prevalent Cases of Atopic Dermatitis

3.5.4 One-Year Total Prevalent Cases of Atopic Dermatitis by Severity

3.5.5 One-Year Diagnosed Prevalent Cases of Atopic Dermatitis

3.5.6 Age-Specific One-Year Diagnosed Prevalent Cases of Atopic Dermatitis

3.5.7 Sex-Specific One-Year Diagnosed Prevalent Cases of Atopic Dermatitis

3.5.8 One-Year Diagnosed Prevalent Cases of Atopic Dermatitis by Severity

3.6 Discussion

3.6.1 Epidemiological Forecast Insight

3.6.2 Limitations of the Analysis

3.6.3 Strengths of the Analysis

4 Appendix

4.1 Bibliography

4.2 About the Authors

4.2.1 Epidemiologist

4.2.2 Reviewers

4.2.3 Global Director of Therapy Analysis and Epidemiology

4.2.4 Global Head and EVP of Healthcare Operations and Strategy

4.3 About GlobalData

4.4 Contact Us

4.5 Disclaimer

List of Tables

Table 1: Risk Factors and Comorbid Conditions Associated with Atopic Dermatitis

Table 1: Risk Factors and Comorbid Conditions Associated with Atopic Dermatitis

List of Figures

Figure 1: One-Year Total Prevalent Cases of AD, Both Sexes, All Ages, N, 2017 and 2027

Figure 2: One-Year Diagnosed Prevalent Cases of AD, Both ...

Figure 1: One-Year Total Prevalent Cases of AD, Both Sexes, All Ages, N, 2017 and 2027

Figure 2: One-Year Diagnosed Prevalent Cases of AD, Both Sexes, All Ages, N, 2017 and 2027

Figure 3: 7MM, Age-Standardized One-Year Total Prevalence of Atopic Dermatitis (%), Both Sexes, All Ages, 2017

Figure 4: 7MM, Sources Used and Not Used to Forecast the One-Year Total and Diagnosed Prevalent Cases of Atopic Dermatitis

Figure 5: 7MM, Sources Used to Forecast the One-Year Total Prevalence by Severity of Atopic Dermatitis

Figure 6: 7MM, Sources Used to Forecast the One-Year Diagnosed Prevalent Cases by Severity of Atopic Dermatitis

Figure 7: 7MM, One-Year Total Prevalent Cases of Atopic Dermatitis, Both Sexes, All Ages, N, 2017

Figure 8: 7MM, Age-Specific One-Year Total Prevalent Cases of Atopic Dermatitis, Both Sexes, All Ages, N, 2017

Figure 9: 7MM, Sex-Specific One-Year Total Prevalent Cases of Atopic Dermatitis, All Ages, N, 2017

Figure 10: 7MM, One-Year Total Prevalent Cases of Atopic Dermatitis by Severity, Both Sexes, All Ages, N, 2017

Figure 11: 7MM, One-Year Diagnosed Prevalent Cases of Atopic Dermatitis, Both Sexes, All Ages, N, 2017

Figure 12: 7MM, Age-Specific One-Year Diagnosed Prevalent Cases of Atopic Dermatitis, Both Sexes, All Ages, N, 2017

Figure 13: 7MM, Sex-Specific One-Year Diagnosed Prevalent Cases of Atopic Dermatitis, All Ages, N, 2017

Figure 14: 7MM, One-Year Diagnosed Prevalent Cases by Severity of Atopic Dermatitis, Both Sexes, All Ages, N, 2017

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports